FLGT PEER ANALYSIS

Fulgent Genetics Inc — metric-by-metric comparison with peers and the industry median

FLGTFulgent Genetics Inc

🇺🇸 USA · NASDAQ · Healthcare · Diagnostics & Research

Value it Duel

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile

FLGTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	FLGT	GENIL	RYM	HLN	SNZ	GSK	Ind. Median
P/E	—	46.82	—	31.38	5.90●	14.00	30.04
P/B	0.62	3.47	0.32●	1.98	0.46	4.57	3.40
EV/EBITDA	—	14.07	—	19.20	20.31	8.41●	20.77
P/S	2.03	1.86	1.11●	3.95	4.25	2.49	4.26

Financial Health
Metric	FLGT	GENIL	RYM	HLN	SNZ	GSK	Ind. Median
Current Ratio	5.31●	1.33	0.55	0.92	0.34	0.79	1.87
Debt/Equity	1.0%●	41.0%	39.0%	52.3%	59.6%	106.7%	49.3%
NetDebt/EBITDA	4.55	1.10	-6.24●	3.50	11.44	1.35	1.92

Profitability
Metric	FLGT	GENIL	RYM	HLN	SNZ	GSK	Ind. Median
Net Margin	-23.0%	4.0%	-60.1%	12.6%	72.0%●	17.8%	6.7%
ROE	-6.8%	8.7%	-16.8%	6.3%	8.2%	36.4%●	6.4%
ROA	-6.2%	4.8%	-5.8%	3.2%	3.0%	9.4%●	3.3%
EBITDA Margin	-18.3%	14.3%	-21.8%	25.2%	47.9%●	35.3%	18.8%

Growth + Dividend
Metric	FLGT	GENIL	RYM	HLN	SNZ	GSK	Ind. Median
Rev. Growth	9.5%	16.3%	215.1%●	-26.7%	13.3%	4.0%	9.1%
NI Growth	—	146.6%●	—	-14.2%	-23.6%	84.9%	12.4%
Div. Yield	—	0.0%	—	2.0%	3.4%●	3.3%	0.8%
Payout	—	0.0%	—	40.0%	12.5%	44.5%	23.2%

Valuation
Metric	FLGT	CSTL	MYGN	NEO	OPK	CDNA	Ind. Median
P/E	—	—	—	—	—	—	30.04
P/B	0.62	1.54	1.63	0.45●	0.94	4.80	3.40
EV/EBITDA	—	—	—	—	—	125.40	20.77
P/S	2.03	2.10	0.66	0.50●	1.95	3.64	4.26

Financial Health
Metric	FLGT	CSTL	MYGN	NEO	OPK	CDNA	Ind. Median
Current Ratio	5.31	6.75●	2.40	4.42	3.61	3.40	1.87
Debt/Equity	1.0%●	8.0%	62.7%	49.3%	33.0%	7.8%	49.3%
NetDebt/EBITDA	4.55	310.00	-0.26	-7.82	-1.59	-15.21●	1.92

Profitability
Metric	FLGT	CSTL	MYGN	NEO	OPK	CDNA	Ind. Median
Net Margin	-23.0%	-3.8%	-48.2%	-13.3%	-36.6%	-2.0%●	6.7%
ROE	-6.8%	-2.8%	-76.7%	-11.6%	-16.9%	-2.4%●	6.4%
ROA	-6.2%	-2.4%	-47.6%	-6.7%	-10.7%	-1.8%●	3.3%
EBITDA Margin	-18.3%	-0.2%	-40.3%	-4.5%	-6.0%	2.6%●	18.8%

Growth + Dividend
Metric	FLGT	CSTL	MYGN	NEO	OPK	CDNA	Ind. Median
Rev. Growth	9.5%	-2.1%	-0.3%	10.9%	-15.7%	19.2%●	9.1%
NI Growth	—	—	—	—	—	—	12.4%
Div. Yield	—	—	—	—	—	—	0.8%
Payout	—	—	—	—	—	—	23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on FLGT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.